Drug tested to shrink heart attack scars
NCT ID NCT07325955
Summary
This study looked at whether a drug called trimetazidine could reduce permanent scarring in the heart after a major heart attack (STEMI). Researchers observed 194 patients who had received standard emergency treatment to open their blocked artery. They used heart scans to measure if taking the drug for six months resulted in less scar tissue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese PLA general hospital
Beijing, Haidian, 100853, China
Conditions
Explore the condition pages connected to this study.